[HTML][HTML] Lessons learned from the use of convalescent plasma for the treatment of COVID-19 and specific considerations for immunocompromised patients
M Beraud, EG Meyer, M Lozano, A Bah… - … and Apheresis Science, 2022 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) convalescent plasma (CovCP) infusions
have been widely used for the treatment of hospitalized patients with COVID-19. The aims of …
have been widely used for the treatment of hospitalized patients with COVID-19. The aims of …
[HTML][HTML] Lessons learned from the use of convalescent plasma for the treatment of COVID-19 and specific considerations for immunocompromised patients
M Beraud, EG Meyer, M Lozano, A Bah… - … and Apheresis Science, 2022 - trasci.com
Abstract Coronavirus disease 2019 (COVID-19) convalescent plasma (CovCP) infusions
have been widely used for the treatment of hospitalized patients with COVID-19. The aims of …
have been widely used for the treatment of hospitalized patients with COVID-19. The aims of …
[HTML][HTML] Lessons learned from the use of convalescent plasma for the treatment of COVID-19 and specific considerations for immunocompromised patients
M Beraud, EG Meyer, M Lozano, A Bah… - Transfusion and …, 2022 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID-19) convalescent plasma (CovCP) infusions
have been widely used for the treatment of hospitalized patients with COVID-19. The aims of …
have been widely used for the treatment of hospitalized patients with COVID-19. The aims of …
Lessons learned from the use of convalescent plasma for the treatment of COVID-19 and specific considerations for immunocompromised patients.
M Beraud, M Lozano, A Bah, R Vassallo… - … : Official Journal of the …, 2022 - europepmc.org
Abstract Coronavirus disease 2019 (COVID-19) convalescent plasma (CovCP) infusions
have been widely used for the treatment of hospitalized patients with COVID-19. The aims of …
have been widely used for the treatment of hospitalized patients with COVID-19. The aims of …
Lessons learned from the use of convalescent plasma for the treatment of COVID-19 and specific considerations for immunocompromised patients
M Beraud, EG Meyer, M Lozano… - … : official journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
Coronavirus disease 2019 (COVID-19) convalescent plasma (CovCP) infusions have been
widely used for the treatment of hospitalized patients with COVID-19. The aims of this …
widely used for the treatment of hospitalized patients with COVID-19. The aims of this …
Lessons learned from the use of convalescent plasma for the treatment of COVID-19 and specific considerations for immunocompromised patients.
M Beraud, M Lozano, A Bah, R Vassallo… - … : Official Journal of the …, 2022 - europepmc.org
Abstract Coronavirus disease 2019 (COVID-19) convalescent plasma (CovCP) infusions
have been widely used for the treatment of hospitalized patients with COVID-19. The aims of …
have been widely used for the treatment of hospitalized patients with COVID-19. The aims of …